|
N-Carbamyl-D-Methionine
|
DB03364 |
|
|
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
|
DB03365 |
|
|
4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN
|
DB04696 |
|
|
1-Hexadecylsulfonyl Fluoride
|
DB02035 |
|
|
Isoluminol
|
DB02041 |
|
|
ZK-806711
|
DB03373 |
|
|
3,5-Diiodotyrosine
|
DB03374 |
[A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE). [PubChem]] |
|
Modified Ribosylated Glutamyl Ester
|
DB03371 |
|
|
1,2-Dipalmitoyl-Phosphatidyl-Glycerole
|
DB02043 |
|
|
3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One
|
DB03372 |
|
|
2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol
|
DB02042 |
|
|
FR239087
|
DB03370 |
|
|
Taspoglutide
|
DB14027 |
[Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche. In September 2010 Roche halted Phase III clinical trials due to incidences of serious hypersensitivity reactions and gastrointestinal side effects. As of May 2013 no new trials had been registered.] |
|
Xanthohumol
|
DB15359 |
[Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome).] |
|
JNJ-54175446
|
DB15358 |
[JNJ-54175446 is under investigation in clinical trial NCT02933762 (A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma).] |
|
Nordazepam
|
DB14028 |
[An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.] |
|
Furafylline
|
DB14029 |
[Furafylline is a derivative of methylxanthine derivative. It was developed on the context of asthma as a long-acting alternative for [theophylline].] |
|
PL-3994
|
DB15355 |
[PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).] |
|
Evinacumab
|
DB15354 |
[Evinacumab is under investigation in clinical trial NCT03146416 (Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers).] |
|
Xanomeline
|
DB15357 |
[Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium).] |
